Select Publications

Book Chapters

Hoque S; Kim C; Desai M; Sirimana P; Schumacher MK; Jasti S; Abasseri M; M.Fisher O; Chu F; Lodh S; Collier N; Liauw W; Milkiewicz P; Zekry A, 2024, 'The Multidisciplinary Management of Primary Hepatocellular Carcinoma', in , Wiley, pp. 321 - 346,

Chen F; Fryer C; Gong L; Zekry A, 2019, 'Hepatitis B virus, hepatitis C virus, the microbiome and hepatocellular carcinoma', in Eslick G (ed.), Gastrointestinal Diseases and Their Associated Infections, Elsevier, pp. 41 - 54

Gong L; Zekry A, 2019, 'Transplantation Immunology', in Reference Module in Biomedical Research, Elsevier

Chen F; Freyer C; Gong L; Zekry A, 2019, 'Chapter 4 Hepatitis B Virus, Hepatitis C Virus, the Microbiome, and Hepatocellular Carcinoma', in Gastrointestinal Diseases and their Associated Infections, Elsevier, pp. 41 - 54,

McHutchison JG; King JM; Zekry A, 2007, 'New drugs for the management of hepatitis C', in Viral Hepatitis, pp. 540 - 552,

Journal articles

Sen Wang D; Phu A; McKee K; Strasser SI; Sheils S; Weltman M; Sellar S; Davis JS; Young M; Braund A; Farrell GC; Blunn A; Harding D; Ralton L; Muller K; Davison SA; Shaw D; Wood M; Hajkowicz K; Skolen R; Davies J; Tate-Baker J; Doyle A; Tuma R; Hazeldine S; Lam W; Edmiston N; Zohrab K; Pratt W; Watson B; Zekry A; Stephens C; Clark PJ; Day M; Park G; Kim H; Wilson M; McGarity B; Menzies N; Russell D; Lam T; Boyd P; Kok J; George J; Douglas MW, 2024, 'Hepatitis C virus antiviral drug resistance and salvage therapy outcomes across Australia', Open Forum Infectious Diseases,

Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Sinclair M; George J; Bollipo S; McGarity B; Sievert W; MacQuillan G; Tse E; Nicoll A; Wade A; Cheng W; Roberts SK, 2024, 'Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care', Journal of Gastroenterology and Hepatology (Australia), 39, pp. 568 - 575,

Singh S; Hoque S; Zekry A; Sowmya A, 2023, 'Radiological Diagnosis of Chronic Liver Disease and Hepatocellular Carcinoma: A Review', Journal of Medical Systems, 47,

Abasseri M; Hoque S; Slavica Kochovska BA; Caldwell K; Sheahan L; Zekry A, 2023, 'Barriers to palliative care in hepatocellular carcinoma: A review of the literature', Journal of Gastroenterology and Hepatology (Australia), 38, pp. 1047 - 1055,

Zhang F; Gia A; Chen G; Gong L; Behary J; Hold GL; Zekry A; Tang X; Sun Y; El-Omar E; Jiang XT, 2023, 'Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients', Viruses, 15,

Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson AJ; Levy M; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2023, 'Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort', Digestive Diseases and Sciences, 68, pp. 291 - 303,

Rajapakse J; Khatiwada S; Akon AC; Yu KL; Shen S; Zekry A, 2023, 'Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions', Gut Microbes, 15,

Zekry A; El-Omar EM, 2022, 'A Tale of Two Fibers: A Liver Twist!', Gastroenterology, 163, pp. 1495 - 1497,

Clark PJ; Valery PC; Ward J; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2022, 'Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up', BMC Gastroenterology, 22,

Maharaj AD; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo EL; Philip J; Strasser SI; Stuart K; Thompson A; Tibballs J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Fink M; Goodwin M; Karapetis CS; Levy MT; Muller K; O'Beirne J; Pryor D; Seow J; Shackel N; Tallis C; Butler N; Olynyk JK; Reed-Cox K; Zalcberg JR; Roberts SK, 2022, 'Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus', Hepatology Communications, 6, pp. 3260 - 3271,

Prince DS; Schlaphoff G; Davison SA; Huo YR; Xiang H; Chan MV; Lee AU; Thailakanathan C; Jebeili H; Rogan C; Al-Omary A; Gupta S; Lockart I; Tiwari N; Clark-Dickson M; Hillhouse JW; Laube R; Chang J; Nguyen V; Danta M; Cheng R; Strasser SI; Zekry A; Levy MT; Chan C; Liu K, 2022, 'Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study', Journal of Gastroenterology and Hepatology (Australia), 37, pp. 2173 - 2181,

Maher S; Rolls S; Pavendranathan G; Westbury S; Akon AC; Zekry A, 2022, 'Virtual clinic for positive faecal occult blood tests enhances early access to bowel cancer screening and is well received by patients', Internal Medicine Journal, 52, pp. 1525 - 1530,

Shen S; Khatiwada S; Behary J; Kim R; Zekry A, 2022, 'Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma', Cancers, 14,

Amorim N; McGovern E; Raposo A; Khatiwada S; Shen S; Koentgen S; Hold G; Behary J; El-Omar E; Zekry A, 2022, 'Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination', Frontiers in Medicine, 9,

Bensted K; Kim C; Freiman J; Hall M; Zekry A, 2022, 'Gastroenterology hospital outpatients report high rates of satisfaction with a Telehealth model of care', Journal of Gastroenterology and Hepatology (Australia), 37, pp. 63 - 68,

Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A, 2021, 'Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model', BMC Microbiology, 21, pp. 113,

Behary J; Amorim N; Jiang XT; Raposo A; Gong L; McGovern E; Ibrahim R; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O’Sullivan J; Weltman M; McCaughan G; El-Omar E; Zekry A, 2021, 'Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma', Nature Communications, 12, pp. 187,

Razavi H; Blach S; Razavi-Shearer D; Abaalkhail F; Abbas Z; Abdallah A; Abrao Ferreira P; Abu Raddad LJ; Adda D; Agarwal K; Aghemo A; Ahmed A; Al-Busafi SA; Al-hamoudi W; Al-Kaabi S; Al-Romaihi H; Aljarallah B; AlNaamani K; Alqahtani S; Alswat K; Altraif I; Asselah T; Bacon B; Bessone F; Bizri AR; Block T; Bonino F; Brandão-Mello CE; Brown K; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Calleja JL; Castro Batänjer E; Chan HLY; Chang H; Chen CJ; Christensen PB; Chuang WL; Cisneros L; Cohen C; Colombo M; Conway B; Cooper C; Craxi A; Crespo J; Croes E; Cryer D; Cupertino de Barros FP; Derbala M; Dillon J; Doss W; Dou X; Doyle J; Duberg AS; Dugan E; Dunn R; Dusheiko G; El Khayat H; El-Sayed MH; Eshraghian A; Esmat G; Esteban Mur R; Ezzat S; Falconer K; Fassio E; Ferrinho P; Flamm S; Flisiak R; Foster G; Fung J; García-Samaniego J; Gish RG; Gonçales F; Halota W; Hamoudi W; Hassany M; Hatzakis A; Hay S; Himatt S; Hoepelman IM; Hsu YC; Hui YT; Hunyady B; Jacobson I; Janjua N; Janssen H; Jarcuska P; Kabagambe K; Kanto T; Kao JH; Kaymakoglu S; Kershenobich D; Khamis F; Kim DJ; Kim DY; Kondili LA; Kottilil S; Kramvis A, 2021, 'The case for simplifying and using absolute targets for viral hepatitis elimination goals', Journal of Viral Hepatitis, 28, pp. 12 - 19,

Alraiyes TM; Alrajhi A; Abou-Al-Shaar H; Zekry A; Alotaibi NM; Aleissa S; Alzayed Z, 2020, 'The Use of Image-Guided Navigation Systems During Spine Surgeries in Saudi Arabia: A Cross-Sectional Study', INTERNATIONAL JOURNAL OF SPINE SURGERY, 14, pp. 1016 - 1022,

Huang T; Behary J; Zekry A, 2020, 'Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management', Internal Medicine Journal, 50, pp. 1038 - 1047,

Finn RS; Qin S; Ikeda M; Galle PR; Ducreux M; Kim T-Y; Kudo M; Breder V; Merle P; Kaseb AO; Li D; Verret W; Xu D-Z; Hernandez S; Liu J; Huang C; Mulla S; Wang Y; Lim HY; Zhu AX; Cheng A-L, 2020, 'Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma', NEW ENGLAND JOURNAL OF MEDICINE, 382, pp. 1894 - 1905,

Nicoll AJ; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy M; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser SI; McCaughan GW, 2019, 'Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels', Alimentary Pharmacology and Therapeutics, 49, pp. 1314 - 1322,

Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR, 2019, 'Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection', Journal of Infectious Diseases, 219, pp. 1430 - 1438,

Brown MA; Gellatley W; Hoffman A; Dowdell L; Camac A; Francois R; Boston B; Zekry A, 2019, 'Medical complications of homelessness: a neglected side of men’s health', Internal Medicine Journal, 49, pp. 455 - 460,

Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92,

Chidwick K; Kiss D; Gray R; Yoo J; Aufgang M; Zekry A, 2018, 'Insights into the management of chronic hepatitis C in primary care using MedicineInsight', Australian journal of general practice, 47, pp. 639 - 645,

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy', Journal of Clinical Nursing, 27, pp. 2673 - 2683,

Brown A; Hézode C; Zuckerman E; Foster GR; Zekry A; Roberts SK; Lahser F; Durkan C; Badshah C; Zhang B; Robertson M; Wahl J; Barr E; Haber B, 2018, 'Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study', Journal of Viral Hepatitis, 25, pp. 457 - 464,

Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G, 2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, 16, pp. 268 - 277,

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Factors associated with non-adherence to HBV antiviral therapy', Antiviral Therapy, 23, pp. 425 - 433,

Sud R; Tiwari N; Forner P; Dowdell L; Freiman J; Zekry A, 2018, 'General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C', Internal Medicine Journal, 48, pp. 105 - 106,

Nicoll A; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy MT; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser S; McCaughan G, 2018, 'Mo1458 - Response to Mycphenolate Mofetil in Patents with Autoimmune Hepatitis who Fail Standard Therapy is Predicted by Serum Gammaglobulin Levels but not Cirrhosis', Gastroenterology, 154, pp. S - 1213,

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078,

Polis S; Zhang L; Mainali B; Pons R; Pavendranathan G; Zekry A; Fernandez R, 2017, 'Factors associated with medication adherence in patients living with cirrhosis (vol 25, pg 204, 2016)', JOURNAL OF CLINICAL NURSING, 26, pp. 3751 - 3751,

Polis S; Zablotska-Manos I; Zekry A; Maher L, 2017, 'Adherence to Hepatitis B antiviral therapy: A qualitative study', Gastroenterology Nursing, 40, pp. 239 - 246,

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; Dore GJ; George J; Maher L, 2017, 'Factors associated with HBV virological breakthrough', Antiviral Therapy, 22, pp. 53 - 60,

Lubel J; Strasser S; Stuart KA; Dore G; Thompson A; Pianko S; Bollipo S; Mitchell JL; Fragomeli V; Jones T; Chivers S; Gow P; Iser D; Levy M; Tse E; Gazzola A; Cheng W; Nazareth S; Galhenage S; Wade A; Weltman M; Wigg A; MacQuillan G; Sasadeusz J; George J; Zekry A; Roberts SK, 2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, 22, pp. 699 - 710,

Lee A; Rode A; Nicoll A; Zekry A; Lim L; Lim S; Angus P; Kronborg I; Arachchi N; McCaughan G; McLennan S; Shackel N, 2017, 'Soluble CD147 has an altered expression profile with liver disease progression and in different ethnicities', JOURNAL OF HEPATOLOGY, 66, pp. S658 - S658,

Dowdell L; Zekry A, 2017, 'P13 Call: community assessment and liver liaison, a liver clinic provided to homeless men in their community', Journal of Virus Eradication, 3, pp. 16 - 17,

Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23, pp. 985 - 993,

Chen FW; Zekry A, 2016, 'Elevated serum ferritin: Identifying iron overload', Medicine Today, 7, pp. 51 - 52

Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; Mclennan SV; Mccaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM, 2015, 'Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study', Journal of Diabetes, 7, pp. 809 - 819,

Zeuzem S; Flisiak R; Vierling JM; Mazur W; Mazzella G; Thongsawat S; Abdurakhmanov D; Van Kinh N; Calistru P; Heo J; Stanciu C; Gould M; Makara M; Hsu S-J; Buggisch P; Samuel D; Mutimer D; Nault B; Merz M; Bao W; Griffel LH; Brass C; Naoumov NV, 2015, 'Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II)', ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 42, pp. 829 - 844,

Zhu AX; Park JO; Ryoo B-Y; Yen C-J; Poon R; Pastorelli D; Blanc J-F; Chung HC; Baron AD; Pfiffer TEF; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang S-C; Abada PB; Yang L; Schwartz JD; Kudo M, 2015, 'Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial', LANCET ONCOLOGY, 16, pp. 859 - 870,

Williams KH; Viera de Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Bu Y; Brooks B; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Bachovchin WW; Keane FM; Zekry A; Twigg SM; Gorrell MD, 2015, 'Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity', Diabetes Research and Clinical Practice, 108, pp. 466 - 472,

Back to profile page